Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series

Molecular indicators of colorectal cancer prognosis have been assessed in several studies, but most analyses have been restricted to a handful of markers. We aimed to identify prognostic biomarkers for colorectal cancer by sequencing panels of multiple driver genes.In stage II or III colorectal canc...

Full description

Bibliographic Details
Main Authors:	Domingo, E, Camps, C, Kaisaki, P, Parsons, M, Mouradov, D, Pentony, M, Makino, S, Palmieri, M, Ward, R, Hawkins, N, Gibbs, P, Askautrud, H, Oukrif, D, Wang, H, Wood, J, Tomlinson, E, Bark, Y, Kaur, K, Johnstone, E, Palles, C, Church, D, Novelli, M, Danielsen, H, Sherlock, J, Kerr, D, Kerr, R, Sieber, O, Taylor, J, Tomlinson, I
Format:	Journal article
Language:	English
Published:	Elsevier 2018

Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series

Similar Items